The Immediate Effect of Kinesio Tape on Hamstring Muscle Length in Female Students of University of Dammam

NCT03076840 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2017-03-21

No results posted yet for this study

Summary

The hamstring muscle is an important muscle that affect the performance of almost all activities of daily living. Since this muscle is a large muscle that pass across two major joints (the hip and knee joint), it is more susceptible to become tight and to lose its extensibility. On the other hand, there is no agreement on a standard protocol for the treatment of hamstring tightness. Kinesio tape is one of the options for treatment of hamstring muscle, it is a safe, passive and non-painful intervention, and if proven to be effective it will help individuals especially those with poor compliance and poor tolerance to painful stretching exercises. The aim of the present study is to investigate the acute effectiveness of Kinesio taping on hamstring muscles extensibility. 96 students with hamstring tightness will be recruited from the University of Dammam to participate in this prospective experimental study. All participants will be assigned randomly to either a Kinesio tape group, Sham tape group and control group. Outcome measures will be the hamstring length measurement by using active knee extension test and strength measurement for hamstring and quadriceps muscles by using a handheld dynamometer. Outcome measurement will be taken at baseline and 15 minutes after the intervention.

Conditions

  • Hamstring Tightness

Interventions

OTHER

Kinesio tape

Kinesio Taping is another option for the treatment of poor hamstring extensibility, It was developed by Kenzo Kase in 1970 and gained a wide popularity by the elite athletes during the various championships and Olympic Games

Sponsors & Collaborators

  • Imam Abdulrahman Bin Faisal University

    lead OTHER

Principal Investigators

  • ennas FA Alanany, Prof · Imam Abdulrahman Bin Faisal University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-17
Primary Completion
2017-04-30
Completion
2017-07-31

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03076840 on ClinicalTrials.gov